Huntington's disease-like 2

A clinical, pathological, and molecular comparison to Huntington's disease

Russell Louis Margolis, Susan E. Holmes

Research output: Contribution to journalArticle

Abstract

Huntington's disease-like 2 (HDL2) is a recently described disorder caused by a CTG/CAG expansion mutation on chromosome 16q24.3. Like Huntington's disease (HD), it is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Almost all known affected individuals are of African ancestry. Pathologically, it is very similar to HD, with prominent cortical and striatal atrophy and intranuclear inclusions. Most surprisingly, however, the available evidence suggests that it is not a polyglutamine disease. Rather, the repeat expansion is located within junctophilin-3 in the CTG orientation. Here we review the clinical, pathological, and molecular features of HDL2 in comparison with HD, and speculate about how the distinct mutations of these disorders lead to such similar clinical and pathological phenotypes.

Original languageEnglish (US)
Pages (from-to)187-196
Number of pages10
JournalClinical Neuroscience Research
Volume3
Issue number3
DOIs
StatePublished - Sep 2003

Fingerprint

Huntington Disease
Corpus Striatum
Intranuclear Inclusion Bodies
Mutation
Dyskinesias
Atrophy
Psychiatry
Dementia
Chromosomes
Phenotype
Huntington Disease-Like 2

Keywords

  • Basal ganglia
  • Caudate
  • Huntington's disease
  • Inclusion
  • Junctophilin
  • Neurodegeneration
  • Striatum
  • Trinuleotide repeat expansion

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Neurology
  • Neuropsychology and Physiological Psychology

Cite this

Huntington's disease-like 2 : A clinical, pathological, and molecular comparison to Huntington's disease. / Margolis, Russell Louis; Holmes, Susan E.

In: Clinical Neuroscience Research, Vol. 3, No. 3, 09.2003, p. 187-196.

Research output: Contribution to journalArticle

@article{40552dccb98f412aa4b883ddf38363bc,
title = "Huntington's disease-like 2: A clinical, pathological, and molecular comparison to Huntington's disease",
abstract = "Huntington's disease-like 2 (HDL2) is a recently described disorder caused by a CTG/CAG expansion mutation on chromosome 16q24.3. Like Huntington's disease (HD), it is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Almost all known affected individuals are of African ancestry. Pathologically, it is very similar to HD, with prominent cortical and striatal atrophy and intranuclear inclusions. Most surprisingly, however, the available evidence suggests that it is not a polyglutamine disease. Rather, the repeat expansion is located within junctophilin-3 in the CTG orientation. Here we review the clinical, pathological, and molecular features of HDL2 in comparison with HD, and speculate about how the distinct mutations of these disorders lead to such similar clinical and pathological phenotypes.",
keywords = "Basal ganglia, Caudate, Huntington's disease, Inclusion, Junctophilin, Neurodegeneration, Striatum, Trinuleotide repeat expansion",
author = "Margolis, {Russell Louis} and Holmes, {Susan E.}",
year = "2003",
month = "9",
doi = "10.1016/S1566-2772(03)00061-6",
language = "English (US)",
volume = "3",
pages = "187--196",
journal = "Clinical Neuroscience Research",
issn = "1566-2772",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Huntington's disease-like 2

T2 - A clinical, pathological, and molecular comparison to Huntington's disease

AU - Margolis, Russell Louis

AU - Holmes, Susan E.

PY - 2003/9

Y1 - 2003/9

N2 - Huntington's disease-like 2 (HDL2) is a recently described disorder caused by a CTG/CAG expansion mutation on chromosome 16q24.3. Like Huntington's disease (HD), it is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Almost all known affected individuals are of African ancestry. Pathologically, it is very similar to HD, with prominent cortical and striatal atrophy and intranuclear inclusions. Most surprisingly, however, the available evidence suggests that it is not a polyglutamine disease. Rather, the repeat expansion is located within junctophilin-3 in the CTG orientation. Here we review the clinical, pathological, and molecular features of HDL2 in comparison with HD, and speculate about how the distinct mutations of these disorders lead to such similar clinical and pathological phenotypes.

AB - Huntington's disease-like 2 (HDL2) is a recently described disorder caused by a CTG/CAG expansion mutation on chromosome 16q24.3. Like Huntington's disease (HD), it is an adult onset, progressive, neurodegenerative autosomal dominant disorder clinically characterized by abnormal movements, dementia, and psychiatric syndromes. Almost all known affected individuals are of African ancestry. Pathologically, it is very similar to HD, with prominent cortical and striatal atrophy and intranuclear inclusions. Most surprisingly, however, the available evidence suggests that it is not a polyglutamine disease. Rather, the repeat expansion is located within junctophilin-3 in the CTG orientation. Here we review the clinical, pathological, and molecular features of HDL2 in comparison with HD, and speculate about how the distinct mutations of these disorders lead to such similar clinical and pathological phenotypes.

KW - Basal ganglia

KW - Caudate

KW - Huntington's disease

KW - Inclusion

KW - Junctophilin

KW - Neurodegeneration

KW - Striatum

KW - Trinuleotide repeat expansion

UR - http://www.scopus.com/inward/record.url?scp=0141605228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141605228&partnerID=8YFLogxK

U2 - 10.1016/S1566-2772(03)00061-6

DO - 10.1016/S1566-2772(03)00061-6

M3 - Article

VL - 3

SP - 187

EP - 196

JO - Clinical Neuroscience Research

JF - Clinical Neuroscience Research

SN - 1566-2772

IS - 3

ER -